Your browser doesn't support javascript.
loading
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.
Sharaf, Radwa; Lee, Guinevere Q; Sun, Xiaoming; Etemad, Behzad; Aboukhater, Layla M; Hu, Zixin; Brumme, Zabrina L; Aga, Evgenia; Bosch, Ronald J; Wen, Ying; Namazi, Golnaz; Gao, Ce; Acosta, Edward P; Gandhi, Rajesh T; Jacobson, Jeffrey M; Skiest, Daniel; Margolis, David M; Mitsuyasu, Ronald; Volberding, Paul; Connick, Elizabeth; Kuritzkes, Daniel R; Lederman, Michael M; Yu, Xu G; Lichterfeld, Mathias; Li, Jonathan Z.
Afiliação
  • Sharaf R; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Lee GQ; Harvard PhD Program in Virology, Division of Medical Sciences, Harvard University, Boston, Massachusetts, USA.
  • Sun X; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
  • Etemad B; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
  • Aboukhater LM; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Hu Z; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Brumme ZL; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Aga E; Simon Fraser University, Burnaby, British Columbia, Canada.
  • Bosch RJ; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Wen Y; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Namazi G; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Gao C; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Acosta EP; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Gandhi RT; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
  • Jacobson JM; University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Skiest D; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
  • Margolis DM; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Mitsuyasu R; Temple University, Philadelphia, Pennsylvania, USA.
  • Volberding P; University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.
  • Connick E; UNC School of Medicine, Chapel Hill, North Carolina, USA.
  • Kuritzkes DR; UCLA, Los Angeles, California, USA.
  • Lederman MM; Gladstone Center for AIDS Research, UCSF, San Francisco, California, USA.
  • Yu XG; University of Arizona College of Medicine, Tucson, Arizona, USA.
  • Lichterfeld M; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Li JZ; Case Western Reserve University, Cleveland, Ohio, USA.
J Clin Invest ; 128(9): 4074-4085, 2018 08 31.
Article em En | MEDLINE | ID: mdl-30024859
ABSTRACT
HIV posttreatment controllers (PTCs) represent a natural model of sustained HIV remission, but they are rare and little is known about their viral reservoir. We obtained 1,450 proviral sequences after near-full-length amplification for 10 PTCs and 16 posttreatment noncontrollers (NCs). Before treatment interruption, the median intact and total reservoir size in PTCs was 7-fold lower than in NCs, but the proportion of intact, defective, and total clonally expanded proviral genomes was not significantly different between the 2 groups. Quantification of total but not intact proviral genome copies predicted sustained HIV remission as 81% of NCs, but none of the PTCs had a total proviral genome greater than 4 copies per million peripheral blood mononuclear cells (PBMCs). The results highlight the restricted intact and defective HIV reservoir in PTCs and suggest that total proviral genome burden could act as the first biomarker for identifying PTCs. Total and defective but not intact proviral copy numbers correlated with levels of cell-associated HIV RNA, activated NK cell percentages, and both HIV-specific CD4+ and CD8+ responses. These results support the concept that defective HIV genomes can lead to viral antigen production and interact with both the innate and adaptive immune systems.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Provírus / Sobreviventes de Longo Prazo ao HIV Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Provírus / Sobreviventes de Longo Prazo ao HIV Idioma: En Ano de publicação: 2018 Tipo de documento: Article